why choose us

First received: October 13, 2023

Clinical Trial: Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Advanced Cancer

Study Type: OBSERVATIONAL


Official Title: Molecular Services and EMR-Laboratory Integration Application (ELIA) for Reducing Leakage and Improving Healthcare Disparities in Cancer Patients

Brief Summary: The goal of this observational study is to measure and try to reduce leakage in precision medicine care in the community cancer clinic.The goal of precision medicine is to identify the best possible therapy the the patient based on the biology of the tumor.Leakage is defined as a failure or inefficiency of the system that leads to dropped or lost testing, reporting or action (including drug selection).It has been observed that there are healthcare disparities in the community setting compared to academic medical…

Read more